SCHEMBL1703145

SCHEMBL1703145

Nc1ncncc1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24198438 0.77
SCHEMBL27947164 0.77
SCHEMBL27721021 0.77 ERN1 (0.33)
SCHEMBL15960866 0.76 EGFR (0.34)
SCHEMBL9131053 0.74 ERN1 (0.36)
SCHEMBL25926334 0.74 EGFR (0.33)
SCHEMBL3700433 0.73
SCHEMBL6338655 0.73
SCHEMBL29955751 0.73
SCHEMBL28146377 0.72 RET (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0704429-B1 2-(Aryliminomethyl)-3-(disubstituted amino)acrylonitriles, a process for their preparation and their use BAYER AG (DE) 1998-06-10 EP claimed
EP-0704429-A1 2-(Aryliminomethyl)-3-(disubstituted amino)acrylonitriles, a process for their preparation and their use BAYER AG (DE) 1996-04-03 EP claimed
US-12617801-B2 Tetrahydrothieno pyridine derivatives as DDRS inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2026-05-05 US disclosed
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 EP disclosed
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
US-20250092040-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. 2025-03-20 US disclosed
EP-4313994-B1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARM SPA (IT) 2025-03-05 EP disclosed
CN-116332859-B Hydrazone compound and preparation method and application thereof 华中师范大学 2025-02-25 CN disclosed
US-20240383915-A1 OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2024-11-21 US disclosed
US-20240239797-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. 2024-07-18 US disclosed
US-20240199635-A1 TETRAHYDROTHIENO PYRIDINE DERIVATIVES AS DDRS INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-06-20 US disclosed
US-5030728-A Cyclic compounds for forming complexes with urea, guanidine and amidine derivatives THE RESEARCH FOUNDATION STATE UNIVERSITY OF NEW YORK (US) 1991-07-09 US disclosed
CN-1048706-A 3-substituted vinyl cephalosporin derivatives and preparation method thereof EISAI CO LTD (JP) 1991-01-23 CN disclosed
EP-0408034-A1 3-Substituted vinyl cephalosporin derivatives Eisai Co., Ltd. (JP) 1991-01-16 EP disclosed
EP-0103126-B1 PROCESS FOR PREPARING 4-AMINO-5-DIALKOXYMETHYLPYRIMIDINE DERIVATIVES UBE INDUSTRIES, LTD. (JP) 1987-03-04 EP disclosed
US-4492792-A Process for preparing 4-amino-5-dialkoxy-methylpyrimidine derivatives UBE INDUSTRIES, LTD. (JP) 1985-01-08 US disclosed
EP-0103126-A1 Process for preparing 4-amino-5-dialkoxymethylpyrimidine derivatives UBE INDUSTRIES, LTD. (JP) 1984-03-21 EP disclosed
EP-0018151-B1 6-SUBSTITUTED-ARYLPYRIDO(2,3-D)PYRIMIDIN-7-AMINES, DERIVATIVES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING ANY OF THE FOREGOING, AND PROCESSES FOR PRODUCING ANY OF THE FOREGOING WARNER-LAMBERT COMPANY (US) 1984-01-25 EP disclosed
US-4271164-A HYPOTENSIVE AGENTS WARNER-LAMBERT COMPANY (US) 1981-06-02 US disclosed
EP-0018151-A1 6-Substituted-arylpyrido(2,3-d)pyrimidin-7-amines, derivatives and salts thereof, pharmaceutical compositions containing any of the foregoing, and processes for producing any of the foregoing WARNER-LAMBERT COMPANY (US) 1980-10-29 EP disclosed